Name | Number of supported studies | Average coverage | |
---|---|---|---|
hematopoietic precursor cell | 3 studies | 36% ± 7% |
Insufficient scRNA-seq data for expression of AZU1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 80% | 96.58 | 369 / 459 | 39% | 2.33 | 440 / 1118 |
lung | 99% | 710.15 | 575 / 578 | 11% | 1.17 | 124 / 1155 |
brain | 78% | 65.57 | 2073 / 2642 | 30% | 0.70 | 213 / 705 |
spleen | 100% | 1577.90 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 5169.31 | 771 / 929 | 0% | 0 | 0 / 0 |
thymus | 49% | 31.32 | 318 / 653 | 20% | 0.71 | 119 / 605 |
liver | 59% | 69.58 | 134 / 226 | 1% | 0.05 | 4 / 406 |
adipose | 58% | 34.96 | 700 / 1204 | 0% | 0 | 0 / 0 |
prostate | 55% | 27.49 | 135 / 245 | 0% | 0.14 | 2 / 502 |
uterus | 50% | 23.16 | 85 / 170 | 3% | 0.22 | 16 / 459 |
blood vessel | 48% | 23.52 | 636 / 1335 | 0% | 0 | 0 / 0 |
bladder | 43% | 18.62 | 9 / 21 | 2% | 0.08 | 12 / 504 |
kidney | 40% | 15.15 | 36 / 89 | 4% | 0.17 | 37 / 901 |
heart | 39% | 37.43 | 336 / 861 | 0% | 0 | 0 / 0 |
ovary | 30% | 11.14 | 54 / 180 | 6% | 0.34 | 27 / 430 |
skin | 33% | 12.76 | 594 / 1809 | 1% | 0.03 | 6 / 472 |
intestine | 30% | 12.26 | 287 / 966 | 1% | 0.05 | 7 / 527 |
pancreas | 9% | 4.42 | 30 / 328 | 16% | 0.86 | 28 / 178 |
adrenal gland | 16% | 5.34 | 42 / 258 | 8% | 0.32 | 18 / 230 |
esophagus | 20% | 9.41 | 286 / 1445 | 2% | 0.03 | 3 / 183 |
muscle | 21% | 10.96 | 171 / 803 | 0% | 0 | 0 / 0 |
stomach | 16% | 5.47 | 58 / 359 | 0% | 0 | 0 / 286 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0042117 | Biological process | monocyte activation |
GO_0006954 | Biological process | inflammatory response |
GO_0045123 | Biological process | cellular extravasation |
GO_0001774 | Biological process | microglial cell activation |
GO_0045348 | Biological process | positive regulation of MHC class II biosynthetic process |
GO_0043114 | Biological process | regulation of vascular permeability |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0051607 | Biological process | defense response to virus |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0035696 | Biological process | monocyte extravasation |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0045860 | Biological process | positive regulation of protein kinase activity |
GO_0019730 | Biological process | antimicrobial humoral response |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006508 | Biological process | proteolysis |
GO_0008347 | Biological process | glial cell migration |
GO_0070944 | Biological process | neutrophil-mediated killing of bacterium |
GO_0070528 | Biological process | protein kinase C signaling |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_0032724 | Biological process | positive regulation of fractalkine production |
GO_0050930 | Biological process | induction of positive chemotaxis |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0060326 | Biological process | cell chemotaxis |
GO_0048246 | Biological process | macrophage chemotaxis |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0042582 | Cellular component | azurophil granule |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0008201 | Molecular function | heparin binding |
GO_0008233 | Molecular function | peptidase activity |
GO_0015643 | Molecular function | toxic substance binding |
GO_0043395 | Molecular function | heparan sulfate proteoglycan binding |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | AZU1 |
Protein name | Azurocidin AZU1 protein Azurocidin (Cationic antimicrobial protein CAP37) (Heparin-binding protein) (HBP) (hHBP) |
Synonyms | |
Description | FUNCTION: This is a neutrophil granule-derived antibacterial and monocyte- and fibroblast-specific chemotactic glycoprotein. Binds heparin. The cytotoxic action is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. It may play a role in mediating recruitment of monocytes in the second wave of inflammation. Has antibacterial activity against the Gram-negative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa. Acting alone, it does not have antimicrobial activity against the Gram-negative bacteria A.actinomycetemcomitans ATCC 29532, A.actinomycetemcomitans NCTC 9709, A.actinomycetemcomitans FDC-Y4, H.aphrophilus ATCC 13252, E.corrodens ATCC 23834, C.sputigena ATCC 33123, Capnocytophaga sp ATCC 33124, Capnocytophaga sp ATCC 27872 or E.coli ML-35. Has antibacterial activity against C.sputigena ATCC 33123 when acting synergistically with either elastase or cathepsin G. . |
Accessions | ENST00000633060.1 ENST00000592205.5 ENST00000233997.4 A0A087WXP0 ENST00000620695.2 Q86SR2 P20160 |